BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 28, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 1, 2009
View Archived Issues
Novel metabotropic glutamate receptor agonists display antiparkinsonian effects in vivo
Read More
Novel amide ketoacid-based inhibitors of HIV integrase show oral antiviral activity
Read More
Affitech shareholders approve proposed merger with Pharmexa
Read More
5-HT6 antagonist AVN-322 deemed a candidate for neurodegenerative diseases
Read More
Roche presents novel TAAR1 ligands
Read More
Novel metalloprotease inhibitors identified by Bracco
Read More
University of California, Oakland claims novel inhibitors of adenylosuccinate synthase
Read More
Novel triazole compounds claimed by Synta Pharmaceuticals
Read More
BPH symptom improvements with dutasteride-tamsulosin combination are clinically relevant
Read More
Herbal formula FAHF-2 effective in multiple food allergy model, safe in humans
Read More
Warner Chilcott has submitted an NDA to the FDA for low-dose oral contraceptive WC-3016
Read More
Small-molecule activator of cardiac myosin increases systolic function in stable heart failure
Read More
Sorafenib may alter ovarian function in women treated for renal cell carcinoma
Read More
GTC receives milestone from Lundbeck following FDA's approval of ATryn
Read More
Spaltudaq changes name to Theraclone and reports results from HIV antibody study
Read More
Detailed phase Ib results for antithrombotic Nanobody ALX-0081 reported by Ablynx
Read More
ExonHit expands neurological research activities to include epilepsy
Read More
Karo Bio reports positive results for KB-3305 in diabetes
Read More
Newron randomizes first patients in phase IIb/III ralfinamide study in pain
Read More
Early treatment with FX-06 and PCI affects outcomes in STEMI patients
Read More
Pharmasset commences first-in-human trial of its HCV inhibitor PSI-7851
Read More
SARcode reports phase I results for its ocular therapeutic, SAR-1118
Read More
Sepracor submits NDA to FDA for Stedesa as adjunctive epilepsy treatment
Read More
Shire and GlaxoSmithKline to co-promote Vyvanse for adult ADHD
Read More
Takeda submits NDA in Japan for Blopress/amlodipine besylate combination
Read More
Acorda Therapeutics receives FDA refuse to file letter for Fampridine-SR NDA
Read More
